维普期刊资源整合服务平台（V6.5）

40篇 您的检索式：作者名="Kaloshi"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Temozolomide for low-grade gliomas: predictive impact of lp/19q loss on response and outcome显示文摘	Kaloshi G Benouaich-Amiel A Diakite F	2007	Neurology2007，68，21：	1
2	MGMT prognostic impact on glioblastoma is dependent on therapeutic modalities显示文摘	Criniere E Kaloshi G LaigleDonadey F	2007	J Neurooncol2007，83，2：	1
3	Multiple gliomas:clinical studies and pathophysiological hypothesis显示文摘	Auré K Laigle-Donadey F Kaloshi G		0，，8：	1
4	IDH1 or IDH2 mutations predict longer survival and response to temozolomide in low-grade gliomas显示文摘	HOUILLIER C WANG X KALOSHI G	2010	Neurology2010，75，17：	1
5	Temozolomide for low-grade gliomas: predictive impact of lp/19q loss on response and outcome 显示文摘	Kaloshi G Benouaicb-Amiel A Diakite F	2007	Neurology2007，68，18：	1
6	MGMT methyration : a marker of re- sponse to temozolomide in low grade gliomas 显示文摘	Everhard S Kaloshi G Criniere E	2006	Ann Neurol2006，60，6：	1
7	Bevacizumab alone at 5 mg/kg in an every-3-week schedule for patients with recurrent glioblasto-mas:a single center experience显示文摘	Kaloshi G Brace G Rroji A		0，，05：	1
8	MGMT methylation :a marker of response to temozolomide in low-grade gliomas显示文摘	Everhard S Kaloshi G Criniere E	2006	Ann Neurol2006，60，6：	1
9	IDH1 or IDH2 muta-tions predict longer survival and response to temozolomidein low-grade gliomas 显示文摘	Houillier C Wang X Kaloshi G	2010	Neurology2010，75，17：	1
10	IDH1 or IDH2 mutations predict longer survival and response to temozolomide in low-grade gliomas显示文摘	Houillier C Wang X Kaloshi G		0，，：	1
11	IDH1 or IDH2 mutations predict longer survival and response to temozolomide in low-grade gliomas显示文摘	Houillier C Wang X Kaloshi G	2010	Neurology2010，75，17：	1
12	Temozolomide for low-grade gliomas: predictive impact of lp/19q loss on response and outcome 显示文摘	Kaloshi G Benouaich-Amiel A Diakite F	2007	Neurology2007，68，：	1
13	Multiple gliomas:clinical studies and pathophysiological hypothesis显示文摘	AURE K LAIGLE-DONDEY F KALOSHI G	2006	Rev Neurol2006，162，89：	1
14	Teraozolomide for low-grade giiomas:predictive impact of 1p/19q loss on response and outcome显示文摘	Kaloshi G Benouaich-Amiel A Diakite F	2007	Neurology2007，68，21：	1
15	Dynamic history of low-grade gliomas before and after temozolonfide treatment显示文摘	Ricard D Kaloshi G Amiel-Benouaieh A	2007	Ann Neurol2007，61，5：	1
16	Temozolomide for low-grade gliomas: predictive impact of lp/19q loss on response and outcome 显示文摘	Kaloshi G Benouaich-Amiel A Diakite F	2007	Neurology2007，68，21：	1
17	Supratentorial Iow- gradegliomas in older patients显示文摘	Kaloshi G Psimaras D Mokhtari K	2009	Neurology2009，73，：	1
18	IDH1 or IDH2 mu-tations predict longer survival and response to temozolomide in low-grade gliomas显示文摘	Houillier C Wang X Kaloshi G	2010	Neurology2010，75，17：	1
19	YR~ M, et al, A Tumor Growth Inhibition Model Chemotherapy or Radiotherapy 显示文摘	RIBBA B KALOSHI G PF	2012	Clinical Cancer Research2012，18，18：	1
20	IDH1 or IDH2 mutations predict longer survival and response to temozolo- mide in low-grade gliomas显示文摘	HOUILLIER C WANG X KALOSHI G l	2010	Neurology2010，75，17：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示